Bahl & Gaynor Inc. lifted its stake in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 0.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 21,440 shares of the medical equipment provider’s stock after purchasing an additional 60 shares during the quarter. Bahl & Gaynor Inc.’s holdings in Smith & Nephew SNATS were worth $645,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. World Asset Management Inc increased its holdings in shares of Smith & Nephew SNATS by 1.0% in the first quarter. World Asset Management Inc now owns 27,656 shares of the medical equipment provider’s stock valued at $855,000 after purchasing an additional 285 shares during the last quarter. Koch Industries Inc. acquired a new stake in shares of Smith & Nephew SNATS in the first quarter valued at approximately $369,000. BTIM Corp. increased its holdings in shares of Smith & Nephew SNATS by 3.2% in the second quarter. BTIM Corp. now owns 65,000 shares of the medical equipment provider’s stock valued at $2,265,000 after purchasing an additional 2,000 shares during the last quarter. Bank of Montreal Can increased its holdings in shares of Smith & Nephew SNATS by 1.3% in the first quarter. Bank of Montreal Can now owns 23,315 shares of the medical equipment provider’s stock valued at $721,000 after purchasing an additional 289 shares during the last quarter. Finally, Earnest Partners LLC increased its holdings in shares of Smith & Nephew SNATS by 28.9% in the first quarter. Earnest Partners LLC now owns 30,239 shares of the medical equipment provider’s stock valued at $935,000 after purchasing an additional 6,774 shares during the last quarter. 6.36% of the stock is owned by hedge funds and other institutional investors.

Several equities research analysts recently commented on the company. Zacks Investment Research raised Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $38.00 price target for the company in a report on Tuesday, July 11th. BidaskClub cut Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a report on Tuesday, July 25th. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Smith & Nephew SNATS currently has a consensus rating of “Buy” and a consensus price target of $38.00.

Shares of Smith & Nephew SNATS, Inc. (SNN) opened at 36.81 on Monday. Smith & Nephew SNATS, Inc. has a 12-month low of $26.97 and a 12-month high of $37.22. The company has a 50 day moving average price of $35.87 and a 200 day moving average price of $33.95. The firm has a market cap of $16.12 billion, a PE ratio of 18.74 and a beta of 0.75.

The business also recently announced a semiannual dividend, which will be paid on Wednesday, November 1st. Investors of record on Friday, October 6th will be paid a $0.246 dividend. This represents a yield of 1.37%. The ex-dividend date is Thursday, October 5th.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/09/18/bahl-gaynor-inc-buys-60-shares-of-smith-nephew-snats-inc-snn.html.

Smith & Nephew SNATS Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew SNATS, Inc. (NYSE:SNN).

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Stock Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related stocks with our FREE daily email newsletter.